Surgery Today https://doi.org/10.1007/s00595-026-03489-5 ORIGINAL ARTICLE Association between Clostridium septicum and Streptococcus gallolyticus bacteremia and colorectal neoplasms Shinnosuke Kai1 · Takashi Ueda2 · Kazuhiko Nakajima2 · Miki Doi3 · Hitoshi Ogashiwa3 · Masanori Uno4 · Akiko Okada4 · Masaya Nakashima4 · Mayuko Fujisawa4 · Hiroyuki Watanabe4 · Yasushi Takenouchi4 · Kosuke Iijima5 · Shinichiro Shinzaki6 · Nobuko Imamura6 · Kozo Kataoka7 · Kei Kimura7 · Motoi Uchino8 · Yuki Horio8 · Ryuichi Kuwahara8 · Yasuhiro Nozaki9 · Yoshio Takesue1 Received: 11 February 2026 / Accepted: 4 September 2026 © The Author(s) 2026 Abstract Purpose Colorectal cancer (CRC) is associated with Clostridium septicum (CS), Streptococcus gallolyticus (SG), and Fusobacterium nucleatum (FN) bacteremia. Further investigation of the mechanism of translocation and the time interval between bacteremia and a CRC diagnosis is required. Methods Patients with bacteremia caused by the three organisms were studied. The organisms were identified using MALDITOF mass spectrometry. Results Fourteen patients (CS [n = 1], SG [n = 11], and FN [n = 2]) were included among 2866 patients with bacteremia. Colorectal neoplasms were detected in two patients at the onset of bacteremia (advanced CRC in patient CS and carcinoma in adenoma in patient SG). Rectal cancer developed 31 months after incidental bacteremia in another patient with SG. Colonoscopy was not performed in 10 of 14 patients, including two patients with FN at the onset of bacteremia and during the follow-up period. Conclusion Consistent with previous reports, we found three typical patterns associated with CRC in patients with CS and SG bacteremia. Because routine colonoscopy was not performed, the true association with CRC could not be determined for these organisms. Keywords Clostridium septicum · Streptococcus gallolyticus · Bacteremia · Carcinogenesis · Colorectal cancer Introduction Several environmental factors, including chemical carcinogens, dietary contaminants, and physical carcinogens, affect cancer development [1]. Microorganisms such as Helicobacter pylori, human papillomavirus, and human hepatitis B and C viruses are also associated with particular malignancies [1]. Gut microbiota dysbiosis may cause colorectal cancer (CRC) [2]. In addition to polyketide synthase-positive Escherichia coli and enterotoxigenic Bacteroides fragilis, Streptococcus gallolyticus, classified as Streptococcus bovis biotype I, and Fusobacterium nucleatum, are well-known major CRC-promoting bacterial species [2, 3]. Shinnosuke Kai and Takashi Ueda have contributed equally to this study. Extended author information available on the last page of the article S. gallolyticus is part of the normal intestinal flora and can cause bacteremia and infective endocarditis (IE) [4]. S. gallolyticus preferentially colonizes colorectal lesions [5, 6], whereas other S. bovis biotypes are not associated with these lesions. S. infantarius (biotype II/1) and S. gallolyticus subsp. pasteurianus (biotype II/2) generally cause biliary tract infections [7, 8]. Although F. nucleatum is a common oral bacterium, oral F. nucleatum may reach colorectal neoplasms using the hematogenous route during transient asymptomatic bacteremia caused by chewing, daily hygiene activities, or dental procedures and reside in these tissues [9–11]. Thus, S. gallolyticus and F. nucleatum are overexpressed in colorectal neoplasia. If certain conditions occur, Surgery Today increased permeability in the inflamed microenvironment induced by these organisms can facilitate translocation to the bloodstream [10, 12]. The mechanism of bacterial translocation, pathophysiological responses, and CRC association pattern are different for C. septicum than for the above-mentioned two organisms [13–16]. The prevalence of fecal carriage of C. septicum is relatively rare, and C. septicum is unlikely to be a normal commensal in humans [17]. C. septicum causes fulminant sepsis with the production of alpha toxin once infections such as atraumatic gas gangrene [18, 19], abdominal infections, and spontaneous bacteremia occur [14]. Evidence has accumulated regarding the relationship between C. septicum infection and malignancy, particularly intestinal or hematological malignancy [20]. An increased hazard risk (HR) of a CRC diagnosis in patients with bacteremia has been shown for C. septicum (HR 23.2), S. gallolyticus (HR 5.38), and F. necrophorum (HR 6.91) compared to patients with negative blood cultures [21]. C. septicum has a sub-hazard ratio of 50.0 for colorectal cancer compared with E. coli as a reference [16]. A strong association between bacteremia and CRC has been reported for these organisms [13–21]. However, further investigation is warranted to determine the mechanism of bacterial translocation and the time interval between the occurrence of bacteremia and a diagnosis of CRC. Methods The study was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments and was approved by the Ethics Committee of Hyogo Medical University Hospital (202512088). The board waived the requirement for informed consent from the patients included in this study, and an opt-out approach was used to obtain consent. Patients admitted to Hyogo Medical University Hospital and Chita Peninsula General Medical Organization Rinku Hospital between January 2021 and September 2025 were retrospectively investigated. Patients in whom C. septicum, S. gallolyticus, or F. nucleatum was isolated from blood and those who were followed up for at least 5 days or until death were included in the study. Patients were excluded if the organisms were considered contaminants. These organisms were considered contaminants for the following reasons: blood was collected through an intravascular catheter or from the femoral site, and resolution of the symptom or laboratory data with inadequate antibiotic use in patients in whom the organisms were recovered only from a single blood culture set among multiple sets collected on the same day. The final decision on blood culture contamination was made by a physician 13 from the Infectious Disease Department based on the clinical course. The BD BACTEC® FX system (Nippon Becton, Dickinson Company, Ltd., Tokyo, Japan) was used for automatic blood culture analyses. Blood samples were inoculated into one aerobic and one anaerobic bottle using BD BACTEC Plus aerobic and Lytic anaerobic media, respectively. AccuRate® Separated Sheep Blood Agar/BTB Lactose Agar (Shimadzu Diagnostics Corporation, Tokyo, Japan) or TSAII 5% sheep blood agar/chocolate II agar 100 sheets (Nippon Becton, Dickinson Company, Ltd.) were used as the culture media. BD Phoenix™ M50 (Nippon Becton Dickinson Company, Ltd.) was used to identify S. gallolyticus. RAPID ID 32 A (bioMerieux Japan Ltd., Tokyo, Japan) was used to identify C. septicum and F. nucleatum. If the preserved organisms were recovered, their identification was confirmed using matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry (MALDI Biotyper; Bruker Daltonics GmbH & Co. KG., Bremen, Germany). Results Among 2866 patients with bacteremia, the number of patients with bacteremia by Escherichia coli was 535 (18.7%) and that of patients with bacteremia by Bacteroides species was 35 (1.22%). The target organisms were isolated from 15 patients (C. septicum in 1 [0.035%] patient, S. gallolyticus in 11 [0.38%] patients, and F. nucleatum in 3 [0.10%] patients). Fourteen patients were analyzed because of loss to follow-up in patients with F. nucleatum bacteremia. Given the extremely small sample size, meaningful statistical comparisons are unlikely to be feasible, and comparisons among these organisms were not performed. MALDI-TOF mass spectrometry was used to identify 12 of the 14 strains. The source of bacteremia was proven in 6 of 14 patients (cholangitis [n = 3], infectious endocarditis [n = 2], infectious spondylitis [n = 1], and pancreatic abscess [n = 1]; one patient had infectious endocarditis and spondylitis) (Table 1). Echocardiography was performed in five patients and magnetic resonance imaging (MRI) in two patients with S. gallolyticus bacteremia. However, these examinations to detect an infectious focus were not performed in patients with C. septicum or F. nucleatum. Colonoscopy was performed at the time of bacteremia in only three patients because of gastrointestinal symptoms and/or colorectal computed tomography (CT) findings, and colorectal neoplasms were detected in two of these patients (Cases 1 and 7). Isolation of these three organisms from blood culture did not result in a work-up to find colorectal neoplasms in Surgery Today Table 1 Antibiotic therapy, infectious focus, imaging tests, performance of an endoscopic examination, and diagnosis for colorectal cancer/ adenoma in patients with bacteremia caused by Clostridium. septicum, Streptococcus gallolyticus, or Fusobacterium nucleatum Case Organism Antimicrobial agents Source of Imaging test Findings of Findings of followno. performed to find colonoscopy up colonoscopy Initial empirical Change based Total bacteremia infectious focus at the time of selection on the identiduraof bacteremia bacteremia fied organisms tion (days) 1 CTRX+CLDM 10 Indeterminant CT Ascending N/A C. septicum CTRX colon (hepatic flexure) cancer 2 MEPM ABPC 18 Indeterminant CT N/A N/A S. gallolyticus 3 CTRX ABPC/SBT 11 Indeterminant TTE, CT N/A Rectal cancer was S. diagnosed 31 months gallolyticus after the time of identifying bacteremia 4 PIPC/TAZ CFPM+MNZ 19 Indeterminant CT, ERCP N/A N/A S. gallolyticus 5 PIPC/TAZ N/A 11 Cholangitis TTE, CT, ERCP N/A N/A S. gallolyticus 6 CTRX N/A 10 Cholangitis CT, ERCP N/A N/A S. gallolyticus 7 ABPC/SBT ABPC + GM, 41, IE, Infectious TEE, MRI, CT Laterally Adenoma with low S. AMPC (p.o.) 646 spondylitis spreadgrade atypia in the gallolyticus (iv + ing tumor in the cecum and transverse p.o.) sigmoid colon colon were found 672 (carcinoma in days after the onset adenoma). 8 MEPM Sitafloxacin 20 Indeterminant CT N/A N/A S. gallolyticus 9 ABPC/SBT ABPC, AMPC 40, 90 IE TEE, MRI, CT No lesion was N/A S. (p.o.) (iv + found gallolyticus p.o.) 10 PIPC/TAZ CTRX 11 Cholangitis ERCP, CT N/A N/A S. gallolyticus 11 ABPC/SBT N/A 1 Indeterminant CT N/A N/A S. gallolyticus 12 CTRX N/A 8 Indeterminant TTE, CT N/A N/A S. gallolyticus / infantarius 13 N/A 11 Pancreatic CT N/A N/A F. nucleatum PIPC/TAZ abscess 14 ABPC/SBT 13 Indeterminant CT N/A N/A (No colonic F. nucleatum MEPM lesion was detected in abdominal CT conducted 725 days after the onset) CTRX=ceftriaxone; MEPM=meropenem; PIPC/TAZ=piperacillin/tazobactam; ABPC/SBT=ampicillin/tazobactam; CLDM=clindamycin; CFPM=cefepime; MNZ=metronidazole; GM=gentamycin; AMPC=amoxicillin; IE=infectious endocarditis; CT=computed tomography; TTE=transthoracic echocardiography; TEE=transesophageal echocardiography; ERCP=endoscopic retrograde cholangiopancreatography; N/ A=not applicable; p.o.=per os; iv=intravenous the remaining 11 patients, although seven of them did not have an obvious source of bacteremia. In one patient (Case 3), in whom neither a concurrent nor a follow-up colorectal examination was performed, rectal cancer was diagnosed 31 months after the onset of bacteremia based on colonoscopy, which was performed because of gross bloody stool (Table 1). The initial empirical antibiotics administered were tazobactam/piperacillin in four patients, meropenem, ceftriaxone, and sulbactam/ampicillin in three patients each, and ceftriaxone in one patient (Table 2). Following the identification of the organism and/or antibiotic susceptibility results, the antibiotics were changed in nine patients (ampicillin [n = 3], sulbactam/ampicillin [n = 2], clindamycin combined with ceftriaxone [n = 1], metronidazole combined 13 Surgery Today Table 2 Patients’ background, information on blood culture, and prognosis in patients with bacteremia caused by Clostridium. septicum, Streptococcus gallolyticus, or Fusobacterium nucleatum Case Organism Method of No. of sets IncubaAge, sex Comorbidity Prognosis no. identification for culture tion time (duration of positive/ (h) follow-up) total set 1 Culture 2/2 sets 9.0/9.0 69, male None Died (1140 C. septicum days) 2 13.13 68, male Pancreatic cancer, chemotherapy, steroid Died (129 days) S. gallolyticus MALDI-TOF MS 1/2 sets 3 10.73 75, male Diabetes, hypertension, atrial fibrillation, Survived (1391 S. gallolyticus MALDI-TOF MS 1/1 set hyperuricemia days) 4 9.77/9.93 68, female Diabetes, gall bladder cancer Died (20 days) S. gallolyticus MALDI-TOF MS 2/2 sets 5 5.53/7,87 91, male Lung cancer, valvular disease of the heart, Died (65 days) S. gallolyticus MALDI-TOF MS 2/2 sets heart failure, chronic renal failure 6 7.18/7.18 84, male Atrial fibrillation, pacemaker, hypertension Survived (606 S. gallolyticus MALDI-TOF MS 2/2 sets days) 7 10.57 78, female Atrial fibrillation, cerebral infarction Survived (687 S. gallolyticus MALDI-TOF MS 2/2 sets /11.07 days) 8 12.53 77, female Myelodysplastic syndrome hypertension, Survived (403 S. gallolyticus MALDI-TOF MS 1/1 set total arthroplasty, steroid days) 9 9.38/9.60 35, male Valvular disease of the heart Survived (315 S. gallolyticus MALDI-TOF MS 2/2 sets days) 10 10.42 82, male Pancreatic cancer (chemotherapy, stent Survived (282 S. gallolyticus MALDI-TOF MS 1/2set placement), hepatitis C without cirrhosis, days) chronic obstructive pulmonary disease) 11 6.32 55, female Renal transplantation (immune suppresDied (0 days) S. gallolyticus MALDI-TOF MS 1/1 set sor), chronic renal failure due to polycystic kidney disease, polycystic liver disease 12 1/2 sets 11 87, male Myocardial infarction, diabetes mellitus, Died (1033 S. gallolyticus / Culture hypertension days) infantarius 13 MALDI-TOF MS 1/2 sets 85.5 86, male Obstructive pancreatitis (stent placement), Survived (20 F. nucleatum lung cancer, hypertension days) 14 MALDI-TOF MS 1/2 sets 61.02 78, male Prostatic cancer (chemotherapy), aortic Died (884 days) F. nucleatum aneurysm MALDI-TOF MS=matrix-assisted laser desorption/ionization time-of-flight mass spectrometry with cefepime [n = 1], ampicillin combined with gentamycin [n = 1], sitafloxacin [n = 1], and ceftriaxone [n = 1]). The percentage of in-hospital mortality was 21.4% (of 3/14 patients). Case no. 1 (69y, male). Concurrent association of advanced colon cancer with C. septicum bacteremia: The patient was transferred to the Emergency Department because of fever, right upper abdominal pain, nausea, and watery diarrhea. Obstructed colitis due to cancer at the hepatic flexure of the ascending colon was suspected on CT and diagnosed by colonoscopy (Fig. 1). C. septicum was isolated from blood specimens, and clindamycin was added to the initially selected ceftriaxone. The minimum inhibitory concentrations (µg/mL) were 0.03 for ampicillin, 2.0 for ceftriaxone, 0.03 for meropenem, 0.13 for clindamycin, and 16 for metronidazole. Highly differentiated adenocarcinoma was confirmed by a histopathological examination of a biopsy specimen. Multiple liver metastases were detected using enhanced CT. Tumor marker results were 106.5 ng/ mL for CEA and 47.8 ng/mL for CA19-9. After resolution of the abdominal symptoms, the patient underwent 13 laparoscopic right hemicolectomy. The size of the type III tumor was 60 × 60 mm, and the colorectal cancer stage was IVc (T4bN2bM1). Although anticancer chemotherapy was initiated, the patient died 1140 days after the initial episodes of bacteremia Case no. 3 (75y, male). Advanced rectal cancer diagnosed with a long interval after identifying S. gallolyticus bacteremia: At the time of onset of bacteremia, transthoracic echocardiography and CT were performed to detect the source of bacteremia, but no infectious foci were identified. Colonoscopy was not performed at that time because the attending physician did not recognize the risk of intestinal neoplasms in patients with S. gallolyticus bacteremia. However, bloody stools developed, and a type II tumor was found in the rectum (group 5, adenocarcinoma) when colonoscopy was performed for the first time since the occurrence of bacteremia (31 months after the episode) (Fig. 2). Polypectomy and endoscopic mucosal resection (EMR) were performed for 16 polyps following the initial colonoscopy (carcinoma [tub1] in adenoma [1 polyp], tubular adenoma with mild atypia [6 polyps], tubular adenoma with mild to moderate Surgery Today Fig. 1 A CT examination on the day of admission and colonoscopy performed on day 10 after hospitalization in Case no. 1. a. The CT value of panniculitis was increased at the site of hepatic flexure. Obstructed colitis due to a tumor was suspected. b. A partially circumferential type III tumor located at the hepatic flexure of the ascending colon was diagnosed Fig. 2 Colonoscopy was performed 944 days after the occurrence of S. gallolyticus bacteremia in Case no. 3. a. A type II tumor of the rectum. b. Multiple polyps that were extracted with polypectomy or EMR atypia [8 polyps], and leiomyoma [1 polyp]). Approximately 1 month after these procedures, the patient underwent robotassisted low anterior resection combined with transanal total mesorectal excision for rectal cancer (Rb). The pathological diagnosis was rectal adenocarcinoma (50 × 45 mm), por2, pT3(A), INFb, Ly1c (D2-40), V1a (EVG), Pn0, pPM0, pDM0, and pRM0. Recurrence with lymph node metastasis in the paraaortic and common iliac arteries was observed on positron emission CT 1 year after surgery Case no. 7 (78y, female). A concurrent diagnosis of carcinoma in adenoma of the colon with S. gallolyticus bacteremia: The patient presented with gastrointestinal symptoms and severe lumbago. The onset of these symptoms was 51 and 35 days before bacteremia, respectively. Gastrointestinal endoscopy was performed because of persistent nausea and continued high C-reactive protein concentrations, and colon polyps were diagnosed. Polypectomy was performed on the lesions of the ascending and sigmoid colon (tubular adenoma with moderate atypia in each). The patient was admitted to Hyogo Medical Hospital for the treatment of a flat elevated lesion (22 mm in diameter) in the sigmoid colon (Fig. 3). Bacteremia with S. gallolyticus developed after admission. Transesophageal echocardiography revealed a string-like mass on the left coronary cusp of the aortic valve, 13 Surgery Today Fig. 3 Colonoscopy was performed during hospitalization when S. gallolyticus bacteremia occurred in Case no. 7. a. Laterally spreading tumor of the sigmoid colon (carcinoma [tub1] in adenoma). b. A his- topathological analysis showed diffuse intensely positive staining for p53 (x 400) at the lesion with severe atypia of the adenoma Fig. 4 MRI was performed during hospitalization when S. gallolyticus bacteremia occurred in Case no. 7. Narrowing in the L3/4 intervertebral disc and abnormal signals of the adjacent upper and lower vertebral bodies were observed (a: T1-weighted image; b: T2-weighted image/STIR) leading to a diagnosis of infectious endocarditis with severe aortic regurgitation. Additionally, narrowing of the L3/4 intervertebral disc and abnormal signals in the adjacent upper and lower vertebral bodies were observed on MRI (Fig. 4). Infectious spondylitis was diagnosed. After completing intravenous antibiotic therapy, endoscopic mucosal resection (EMR) was performed for a laterally spreading tumor of the sigmoid colon. A histopathological analysis 13 showed diffuse intensely positive staining for p53 (Fig. 3) at the lesion with severe atypia of the adenoma (tub1) (22 mm in diameter) without vascular invasion. Polypectomy for the sigmoid colon adenoma (10 mm) was also performed. A follow-up colonoscopy was performed after 672 days, and EMR and polypectomy were performed for the polyps located in the cecum and transverse colon, respectively (tubular adenoma, low-grade atypia in each) Surgery Today Fig. 5 Hypothetical model for type of colorectal neoplasms associated with bacteremia by C. septicum and S. gallolyticus. a. C. septicum reaches the blood through macroscopic ulcerations of the mucosa in a large carcinoma and generally causes sepsis. b. A small lesion, Discussion An association between colorectal neoplasms and bacteremia was observed in one patient with C. septicum and two patients with S. gallolyticus. However, no colorectal neoplasm was identified in two patients with F. nucleatum bacteremia because the present study was underpowered to evaluate the association of F. nucleatum with colorectal neoplasia, and adequate colorectal surveillance was not performed in these patients. There are three patterns of association between colorectal neoplasms and bacteremia [13]. (1) Bacteremia occurred due to advanced cancer with a gross deficit of the mucosa, (2) bacteremia occurred due to an adenoma or cancer in situ without ulceration of the mucosa, and (3) development of cancer with a prolonged elapsed time after the presentation of bacteremia. Our findings are consistent with the hypothesis proposed by Corredoira et al. [13] (Fig. 5). Pattern 1 was observed in Case 1 with C. septicum, whereas patterns 2 and 3 were observed in Cases 7 and 3 with S. gallolyticus. However, it should be stressed that the true prevalence of synchronous or asynchronous development of colorectal neoplasia cannot be determined in C. septicum, S. gallolyticus, and F. nucleatum in the present study, because concurrent or surveillance colonoscopy was not performed in the majority of patients. Corredoira et al. [13] reported that the percentage of adenoma and carcinoma in situ was 80.4% in S. gallolyticus, whereas that of invasive cancer was 94.7% in C. septicum and more than half of the patients were classified as stages including adenoma or carcinoma in adenoma causes bacteremia and rarely develops intestinal symptoms in S. gallolyticus. Several months or years later, colorectal carcinoma may develop because of carcinogenesis caused by S. gallolyticus III or IV. Hypothetically, invasive cancer might provide a favorable environment for C. septicum to reside, proliferate, and enter the bloodstream. (Fig. 5) Tumor lesions are associated with ischemia and even necrosis in the crater of the carcinoma, which decreases the pH, favoring the germination of spores [22]. In contrast, S. gallolyticus involved in early carcinogenesis induces several inflammatory cytokines, which could also facilitate this bacterium to enter the blood circulation by a paracellular mechanism [6, 22]. A study showed that a new colorectal neoplasm developed in half of the patients with S. gallolyticus bacteremia within 42 months of follow-up [13]. Justesen et al. [15] reported that the median number of days to CRC diagnosis after bacteremia was 975 in patients with S. bovis, including S. gallolyticus, and 778 in those with F. nucleatum. A prospective study showed that 45% of patients with IE due to S. gallolyticus developed colonic neoplastic lesions within 5 years of diagnosis [23]. Boleij et al. suggested the need for a follow-up colorectal surveillance examination in patients with S. gallolyticus, which is a well-known promoter of carcinogenesis [24]. CRC would have developed during the time between the episode of bacteremia and the diagnosis of CRC in Case 3, in whom the elapsed time from identifying bacteremia to diagnosing CRC was 31 months. Bacteroides species were isolated from blood cultures of 35 patients in this study. Enterotoxigenic Bacteroides fragilis has been shown to exert effects on colorectal carcinogenesis [25]. In addition, Justesen et al. [16] reported that bacteremia caused by Bacteroides ovatus or Bacteroides uniformis was associated with an increased risk of CRC 13 Surgery Today diagnosis. However, considering the number of colorectal examinations needed to identify one colorectal neoplasm case, the studied organisms with infrequent isolation from blood culture would be promising candidates for colorectal workup rather than B. fragilis group, which is almost exclusively found in the colon. This study has several limitations. First, colonoscopy was performed only in patients with abdominal symptoms or abnormal CT findings, and asymptomatic patients with colorectal neoplasms might have been overlooked. Therefore, comparisons among bacterial species were not feasible using the patients described in this study. Although colorectal neoplasms have not been identified in patients with F. nucleatum bacteremia, F. nucleatum has been increasingly recognized as a microorganism associated with colorectal carcinogenesis [10, 11, 15, 16, 21]. Second, MALDI-TOF mass spectrometry libraries have limited capabilities for the differential identification of S. bovis/S. equinus-complex subspecies, including S. gallolyticus, S. infantarius, S. lutetiensis, and S. equinus [26]. Considering that biliary tract infection is a major cause of bacteremia in S. infantarius and S. lutetiensis [7], missed identification might explain why bacterial cholangitis was associated with S. gallolyticus bacteremia in three of 11 patients. Third, to suspect the translocation of bacteria from the gut to the bloodstream through neoplasms, evidence of colonization of these bacteria on the surface of neoplasms is required. Fourth, the reason for the frequent recurrence of bacteremia was not encountered after the initial episode in Case No. 3. In conclusion, three different typical patterns of association between colorectal neoplasms and bacteremia were reported in one patient with C. septicum bacteremia and two patients with S. gallolyticus bacteremia. Given the retrospective design, very small sample size, limited rate of colorectal workup, and absence of direct microbiological evidence, the present findings should be regarded as hypothesis-generating observations rather than evidence supporting distinct mechanisms of colorectal carcinogenesis. A prospective study with rigorous colorectal examination is required to prove the hypothesis when C. septicum, S. gallolyticus or F. nucleatum are isolated from blood cultures. Acknowledgements We thank Ellen Knapp, PhD, from Edanz ​(​h​t​t​p​s​:​/​ /​j​p​.​e​d​a​n​z​.​co​ ​m​/​ac​ ​​​​) for editing a draft of this manuscript. Author contributions Shinnosuke Kai: Data Curation, Investigation, Writing – Original Draft Preparation, Writing – Review & Editing. Takashi Ueda: Data Curation, Formal Analysis, Investigation, Visualization, Writing – Original Draft Preparation, Writing – Review and Editing. Kazuhiko Nakajima: Supervision. Miki Doi: Investigation. Hitoshi Ogashiwa: Investigation and writing. Masanori Uno: Investigation. Akiko Okada: Investigation. Masaya Nakashima: Investigation. Mayuko Fujisawa: Investigation. Hiroyuki Watanabe: Investigation. Yasushi Takenouchi: Investigation and writing. Kosuke Iijima: Investigation and writing. Shinichiro Shinzaki: Investigation and writ- 13 ing. Nobuko Imamura: Investigation. Kozo Kataoka: Investigation and supervision. Kei Kimura: Investigation and writing. Motoi Uchino: Investigation. Yuki Horio: Investigation and writing. Ryuichi Kuwahara: Investigation. Yasuhiro Nozaki: Investigation and writing. Yoshio Takesue: Conceptualization, Funding Acquisition, Methodology, Project Administration, Writing – Original Draft Preparation, Writing – Review and Editing. All authors provided substantial input for the drafting and review of the manuscript. All authors have read and approved the final manuscript. Funding This research did not receive any specific grants from funding agencies in the public, commercial, or not-for-profit sectors. Declarations Conflict of interest All authors report no potential conflicts of interest. Ethical approval Approval for this study was obtained by the Ethics Committee of Hyogo Medical University Hospital (202512-088). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit ​h​t​t​​p​:​/​/​​c​r​e​​a​t​i​​v​e​c​o​m​m​o​n​s​.​o​ r​g​/​l​i​c​e​n​s​e​s​/​b​y​/​4​.​0​/​​​​.​​​ References 1. 2. 3. 4. 5. 6. 7. Minamoto T, Mai M, Ronai Z. Environmental factors as regulators and effectors of multistep carcinogenesis. Carcinogenesis. 1999;20:519–27. https:/​/doi.or​g/10.10​93/ca​rcin/20.4.519. Qu R, Zhang Y, Ma Y, Zhou X, Sun L, Jiang C, et al. Role of the Gut Microbiota and Its Metabolites in Tumorigenesis or Development of Colorectal Cancer. Adv Sci (Weinh). 2023;10:e2205563. https:/​/doi.or​g/10.10​02/ad​vs.202205563. Dejea CM, Fathi P, Craig JM, Boleij A, Taddese R, Geis AL, et al. Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria. Science. 2018;359:592–7. https:/​/doi.or​g/10.11​26/sc​ience.aah3648. Sitthicharoenchai P, Burrough ER, Arruda BL, Sahin O, Dos Santos JG, Magstadt DR, et al. Streptococcus gallolyticus and bacterial endocarditis in swine, United States, 2015–2020. Emerg Infect Dis. 2022;28:192–5. https:/​/doi.or​g/10.32​01/ei​d2801.210998. Hensler ME. Streptococcus gallolyticus, infective endocarditis, and colon carcinoma: new light on an intriguing coincidence. J Infect Dis. 2011;203:1040–2. ​h​t​t​​p​s​:​/​​/​d​o​​i​.​o​​r​g​/​1​0​.​1​0​9​3​/​i​n​f​d​i​s​/​j​i​q​1​7​ 0​​​​​.​​​ Abdulamir AS, Hafidh RR, Abu Bakar FJ. The association of Streptococcus bovis/gallolyticus with colorectal tumors: the nature and the underlying mechanisms of its etiological role. Exp Clin Cancer Res. 2011;30:11. https:/​/doi.or​g/10.11​86/17​ 56-9966-30-11. Corredoira J, Alonso MP, García-Garrote F, García-Pais MJ, Coira A, Rabuñal R, et al. Streptococcus bovis group and biliary Surgery Today 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. tract infections: an analysis of 51 cases. Clin Microbiol Infect. 2014;20:405–9. https:/​/doi.or​g/10.11​11/14​69-0691.12333. Marmolin ES, Hartmeyer GN, Christensen JJ, Nielsen XC, Dargis R, Skov MN, et al. Bacteremia with the bovis group streptococci: species identification and association with infective endocarditis and with gastrointestinal disease. Diagn Microbiol Infect Dis. 2016;85:239–42. ​h​t​t​​p​s​:​/​​/​d​o​​i​.​o​​r​g​/​1​0​.​1​0​1​6​/​j​.​d​i​a​g​m​i​c​r​o​b​i​o​.​2​0​1​6​.​0​2​ .​0​1​9​​​​.​​​ Masood L, Müller A, Ali NZ, Mummadisetty A, Yahya A, Burugu SS, et al. A Narrative Literature Review on Sepsis: A Primary Manifestation of Colorectal Neoplasm. Cureus. 2023;15:e44803. https:/​/doi.or​g/10.77​59/cu​reus.44803. Abed J, Maalouf N, Manson AL, Earl AM, Parhi L, Emgård JEM, et al. Colon Cancer-Associated Fusobacterium nucleatum May Originate From the Oral Cavity and Reach Colon Tumors via the Circulatory System. Front Cell Infect Microbiol. 2020;10:400. https:/​/doi.or​g/10.33​89/fc​imb.2020.00400. Zepeda-Rivera M, Minot SS, Bouzek H, Wu H, Blanco-Míguez A, Manghi P, et al. A distinct Fusobacterium nucleatum clade dominates the colorectal cancer niche. Nature. 2024;628:424–32. https:/​/doi.or​g/10.10​38/s4​1586-024-07182-w. Abdulamir AS, Hafidh RR, Bakar FA. Molecular detection, quantification, and isolation of Streptococcus gallolyticus bacteria colonizing colorectal tumors: inflammation-driven potential of carcinogenesis via IL-1, COX-2, and IL-8. Mol Cancer. 2010;9:249. https:/​/doi.or​g/10.11​86/14​76-4598-9-249. Corredoira J, Grau I, Garcia-Rodriguez JF, García-País MJ, Rabuñal R, Ardanuy C, et al. Colorectal neoplasm in cases of Clostridium septicum and Streptococcus gallolyticus subsp. gallolyticus bacteraemia. Eur J Intern Med. 2017;41:68–73. ​h​t​t​​p​s​:​/​​/​d​ o​​i​.​o​​r​g​/​1​0​.​1​0​1​6​/​j​.​e​j​i​m​.​2​0​1​7​.​0​2​.​0​0​9​​​​.​​​​ Mirza NN, McCloud JM, Cheetham MJ. Clostridium septicum sepsis and colorectal cancer: a reminder. World J Surg Oncol. 2009;7:73. https:/​/doi.or​g/10.11​86/14​77-7819-7-73. Justesen US, Nielsen SL, Jensen TG, Dessau RB, Møller JK, Coia JE, et al. Bacteremia With Anaerobic Bacteria and Association With Colorectal Cancer: A Population-based Cohort Study. Clin Infect Dis. 2022;75:1747–53. ​h​t​t​​p​s​:​/​​/​d​o​​i​.​o​​r​g​/​1​0​.​1​0​9​3​/​c​i​d​/​c​i​a​c​2​5​9​​​​ .​​​ Justesen US, Ellebæk MB, Qvist N, Iachina M, Frimodt-Møller N, Søes LM, et al. Colorectal cancer and association with anaerobic bacteraemia: A Danish nationwide population-based cohort study. J Infect. 2024;89:106212. ​h​t​t​​p​s​:​/​​/​d​o​​i​.​o​​r​g​/​1​0​.​1​0​1​6​/​j​.​j​i​n​f​.​2​0​ 2​4​.​1​0​6​2​1​2​​​​.​​​ Kopliku FA, Schubert AM, Mogle J, Schloss PD, Young VB, Aronoff DM. Low prevalence of Clostridium septicum fecal 18. 19. 20. 21. 22. 23. 24. 25. 26. carriage in an adult population. Anaerobe. 2014;32:34–6. ​h​t​t​​p​s​:​ /​​/​d​o​​i​.​o​​r​g​/​1​0​.​1​0​1​6​/​j​.​a​n​a​e​r​o​b​e​.​2​0​1​4​.​1​2​.​0​0​1​​​​.​​​​ Turban A, Joussellin V, Piau C, Cattoir V, Launey Y, Eustache G. Fatal Clostridium septicum gas gangrene complicating ECMO: case report and review of literature. Access Microbiol. 2024;6:000825. https:/​/doi.or​g/10.10​99/ac​mi.0.000825.v3. Srivastava I, Aldape MJ, Bryant AE, Stevens DL, Spontaneous C. septicum gas gangrene: A literature review. Anaerobe. 2017;48:165–71. https:/​/doi.or​g/10.10​16/j.​anaerobe.2017.07.008. Kornbluth AA, Danzig JB, Bernstein LH. Clostridium septicum infection and associated malignancy. Report of 2 cases and review of the literature. Med (Baltim). 1989;68:30–7. ​h​t​t​​p​s​:​/​​/​d​o​​i​.​ o​​r​g​/​1​0​.​1​0​9​7​/​0​0​0​0​5​7​9​2​-​1​9​8​9​0​1​0​0​0​-​0​0​0​0​2​​​​.​​​​ Kwong TNY, Wang X, Nakatsu G, Chow TC, Tipoe T, Dai RZW, et al. Association Between Bacteremia From Specific Microbes and Subsequent Diagnosis of Colorectal Cancer. Gastroenterology. 2018;155:383–e3908. ​h​t​t​​p​s​:​/​​/​d​o​​i​.​o​​r​g​/​1​0​.​1​0​5​3​/​j​.​g​a​s​t​r​o​.​2​0​1​8​.​ 0​4​.​0​2​8​​​​.​​​ Corredoira J, Ayuso B. Bacteremia and colon cancer: Causality or coincidence? Enferm Infect Microbiol Clin (Engl Ed). 2022;40:221–3. https:/​/doi.or​g/10.10​16/j.​eimce.2022.02.012. Corredoira J, García-País MJ, Coira A, Rabuñal R, GarcíaGarrote F, Pita J, et al. Differences between endocarditis caused by Streptococcus bovis and Enterococcus spp. and their association with colorectal cancer. Eur J Clin Microbiol Infect Dis. 2015;34:1657–65. https:/​/doi.or​g/10.10​07/s1​0096-015-2402-1. Boleij A, Roelofs R, Danne C, Bellais S, Dramsi S, et al. Selective antibody response to Streptococcus gallolyticus pilus proteins in colorectal cancer patients. Cancer Prev Res (Phila). 2012;5:260– 5. https:/​/doi.or​g/10.11​58/19​40-6207.CAPR-11-0321. Wu S, Rhee KJ, Albesiano E, Rabizadeh S, Wu X, et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med. 2009;15:1016–22. https:/​/doi.or​g/10.10​38/nm​.2015. Öberg J, Engberg A, Inghammar M, Nilson B. Creation and validation of improved MALDI-TOF MS libraries for S. bovis-S. equinus-complex subspecies identification adapted to diagnostic culturing and extraction conditions. Diagn Microbiol Infect Dis. 2025;113:117000. ​h​t​t​​​​p​​s​:​​/​​/​d​​​o​​i​.​o​r​g​​/​1​​0​.​1​0​1​6​/​j​.​d​i​a​g​m​i​c​r​o​b​i​o​.​2​0​2​5​.​1​ 1​7​0​0​0​​​​.​​​ Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. 13 Surgery Today Authors and Affiliations Shinnosuke Kai1 · Takashi Ueda2 · Kazuhiko Nakajima2 · Miki Doi3 · Hitoshi Ogashiwa3 · Masanori Uno4 · Akiko Okada4 · Masaya Nakashima4 · Mayuko Fujisawa4 · Hiroyuki Watanabe4 · Yasushi Takenouchi4 · Kosuke Iijima5 · Shinichiro Shinzaki6 · Nobuko Imamura6 · Kozo Kataoka7 · Kei Kimura7 · Motoi Uchino8 · Yuki Horio8 · Ryuichi Kuwahara8 · Yasuhiro Nozaki9 · Yoshio Takesue1 Yoshio Takesue takesuey@hyo-med.ac.jp Kei Kimura k-kimura@hyo-med.ac.jp Shinnosuke Kai shin.k.hig@gmail.com Motoi Uchino uchino2s@hyo-med.ac.jp Takashi Ueda taka76@hyo-med.ac.jp Yuki Horio yu-horio@hyo-med.ac.jp Miki Doi toko-bisei@ymail.ne.jp Ryuichi Kuwahara ri-kuwahara@hyo-med.ac.jp Hitoshi Ogashiwa hi.ogashiwa@chitahantogmo.or.jp Yasuhiro Nozaki goblue0239@gmail.com Masanori Uno masanori-u@outlook.jp 1 Akiko Okada aokada26@gmail.com Department of Infection Prevention and Control, Chita Peninsula General Medical Organization, Rinku Hospital, 3-3-3 Asukadai, Tokoname 479-8510, Aichi, Japan 2 Masaya Nakashima masaya81973@gmail.com Department of Infection Prevention and Control, Hyogo Medical University Hospital, Nishinomiya, Japan 3 Mayuko Fujisawa k.mayuko_0406@icloud.com Department of Clinical Technology, Chita Peninsula General Medical Organization, Rinku Hospital, Tokoname, Japan 4 Hiroyuki Watanabe nabe_1689@hotmail.com Department of Surgery, Chita Peninsula General Medical Organization, Rinku Hospital, Tokoname, Japan 5 Yasushi Takenouchi tkdr-3692@tac-net.ne.jp Department of Clinical Technology, Hyogo Medical University Hospital, Nishinomiya, Japan 6 Kosuke Iijima ko-iizima@hyo-med.ac.jp Department of Gastroenterology, Hyogo Medical University School of Medicine, Nishinomiya, Japan 7 Shinichiro Shinzaki sh-shinzaki@hyo-med.ac.jp Division of lower GI, Department of Gastroenterological surgery, Hyogo Medical University, Nishinomiya, Japan 8 Division of Inflammatory Bowel Disease Surgery, Department of Gastroenterological Surgery, Hyogo Medical University, Nishinomiya, Japan 9 Department of Respiratory Medicine, Chita Peninsula General Medical Organization, Rinku Hospital, Tokoname, Japan Nobuko Imamura no-kamoda@hyo-med.ac.jp Kozo Kataoka ko-kataoka@hyo-med.ac.jp 13